JP2019512489A5 - - Google Patents

Download PDF

Info

Publication number
JP2019512489A5
JP2019512489A5 JP2018547943A JP2018547943A JP2019512489A5 JP 2019512489 A5 JP2019512489 A5 JP 2019512489A5 JP 2018547943 A JP2018547943 A JP 2018547943A JP 2018547943 A JP2018547943 A JP 2018547943A JP 2019512489 A5 JP2019512489 A5 JP 2019512489A5
Authority
JP
Japan
Prior art keywords
mir
seq
nucleic acid
mimic
mimetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018547943A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019512489A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/021178 external-priority patent/WO2017156015A2/en
Publication of JP2019512489A publication Critical patent/JP2019512489A/ja
Publication of JP2019512489A5 publication Critical patent/JP2019512489A5/ja
Pending legal-status Critical Current

Links

JP2018547943A 2016-03-07 2017-03-07 マイクロｒｎａおよびその使用方法 Pending JP2019512489A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662304844P 2016-03-07 2016-03-07
US62/304,844 2016-03-07
PCT/US2017/021178 WO2017156015A2 (en) 2016-03-07 2017-03-07 Micrornas and methods of their use

Publications (2)

Publication Number Publication Date
JP2019512489A JP2019512489A (ja) 2019-05-16
JP2019512489A5 true JP2019512489A5 (enExample) 2020-03-26

Family

ID=58361152

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018547943A Pending JP2019512489A (ja) 2016-03-07 2017-03-07 マイクロｒｎａおよびその使用方法

Country Status (7)

Country Link
US (2) US11655469B2 (enExample)
EP (1) EP3426781B1 (enExample)
JP (1) JP2019512489A (enExample)
CN (3) CN117757795A (enExample)
DK (1) DK3426781T3 (enExample)
ES (1) ES2986046T3 (enExample)
WO (1) WO2017156015A2 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3492607A3 (en) * 2017-11-30 2019-08-14 Università Degli Studi Di Torino Urinary mirnas for the in vitro diagnosis of bladder cancer
WO2020227604A1 (en) * 2019-05-08 2020-11-12 Nova Southeastern University Regulation of nucleotide excision repair (ner) by microrna for treatment of breast cancer
WO2020245822A1 (en) * 2019-06-03 2020-12-10 Carmel Haifa University Economic Corporation Ltd. Human head and neck cancer treatment
CN111235274A (zh) * 2020-01-18 2020-06-05 山西医科大学第一医院 喉鳞癌血清外泌体标志物筛选方法和外泌体来源miR-941应用
IL296957A (en) * 2020-04-02 2022-12-01 Mirecule Inc Targeted inhibition using engineered oligonucleotides
CN112007043B (zh) * 2020-08-24 2021-07-20 谢琦 抗结直肠癌的药物或组合物
WO2022056454A2 (en) * 2020-09-14 2022-03-17 President And Fellows Of Harvard College Methods and compositions for treating hpv-positive cancers
CN112294960B (zh) * 2020-10-30 2022-02-08 浙江大学 微小分子RNA-30b-5p作为靶分子的用途
CN112359115B (zh) * 2020-11-30 2022-08-30 河北仁博科技有限公司 与肿瘤细胞顺铂耐药性相关的miR-517a-3p及其应用
CN112481273B (zh) * 2020-12-29 2023-11-24 南通大学附属医院 结直肠癌抑癌基因及其启动子区高dna甲基化的验证方法
EP4124656A1 (en) * 2021-07-26 2023-02-01 Martin-Luther-Universität Halle-Wittenberg Pd-l1 micrornas
CN113528669A (zh) * 2021-08-19 2021-10-22 柳州市工人医院 一种利用Small RNA测序技术揭示miRNA对肝癌作用机制的方法
US20250101525A1 (en) * 2022-01-21 2025-03-27 Griffith University Biomarkers and uses therefor
CN114574596B (zh) * 2022-03-11 2023-06-23 浙江省农业科学院 SNPs分子标记g.43851G＞A及其在湖羊分子标记辅助育种中的应用
CN115161321B (zh) * 2022-06-24 2023-04-18 天津市农业科学院 ssc-miR-30c-3p在制备抗PDCoV增殖药物中的应用
CN120035667A (zh) * 2022-07-10 2025-05-23 普雷西根公司 用于免疫检查点抑制的多顺反子miRNA构建体
WO2024142962A1 (ja) * 2022-12-28 2024-07-04 学校法人自治医科大学 腹膜播種抑制剤、腹膜播種抑制方法、腹膜播種予防方法、及び腹膜播種治療方法
TW202444389A (zh) * 2023-01-30 2024-11-16 中央研究院 藉由調節mir34治療脊髓性肌肉萎縮症(sma)以及mir34作為sma的預測生物標記的用途
EP4417709A1 (en) * 2023-02-14 2024-08-21 Gemeinnützige Salzburger Landeskliniken Betriebsges.mbH Mirna-based diagnostic assay for the detection of a risk to develop skin tumors against the background of severe skin lesions
AU2024239300A1 (en) * 2023-03-23 2025-10-23 Purdue Research Foundation Fully modified mir-34a and related conjugates, compositions and methods of use

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US5019369A (en) 1984-10-22 1991-05-28 Vestar, Inc. Method of targeting tumors in humans
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
SI1504126T1 (sl) 2002-05-03 2014-08-29 Duke University Office Of Science And Technology Postopek regulacije izraĹľanja genov
WO2005017145A1 (ja) * 2003-08-13 2005-02-24 Japan Biological Informatics Consortium 機能性ｒｎａが制御する被制御遺伝子の同定・予測方法及びその利用方法
EP1768998A2 (en) 2004-04-27 2007-04-04 Alnylam Pharmaceuticals Inc. Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety
CA2562151C (en) 2004-04-30 2016-09-06 Alnylam Pharmaceuticals, Inc. Oligonucleotides comprising a c5-modified pyrimidine
EP1789553B1 (en) 2004-06-30 2014-03-26 Alnylam Pharmaceuticals Inc. Oligonucleotides comprising a non-phosphate backbone linkage
AU2005328382C1 (en) 2004-07-21 2013-01-24 Alnylam Pharmaceuticals, Inc. Oligonucleotides comprising a modified or non-natural nucleobase
EP1797183B1 (en) * 2004-09-02 2012-08-01 Yale University Regulation of oncogenes by micrornas
JP2006248978A (ja) 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
EP1904111A4 (en) 2005-06-03 2009-08-19 Univ Johns Hopkins COMPOSITIONS AND METHODS FOR REDUCING MICRORNA EXPRESSION FOR THE TREATMENT OF NEOPLASIA
US20070213292A1 (en) 2005-08-10 2007-09-13 The Rockefeller University Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
EP2796554A3 (en) 2005-09-12 2014-12-10 The Ohio State University Research Foundation Compositions for use in treating BCL2-associated cancers
US8603991B2 (en) 2005-11-18 2013-12-10 Gradalis, Inc. Individualized cancer therapy
BRPI0619755A2 (pt) 2005-12-12 2011-10-18 Univ North Carolina micrornas que regulam a proliferação e diferenciação de células musculares
CN101389770B (zh) 2006-01-05 2013-11-06 俄亥俄州立大学研究基金会 用于诊断和治疗实体癌的基于微小rna的方法和组合物
WO2007143752A2 (en) 2006-06-09 2007-12-13 The Regents Of The University Of California Targets in breast cancer for prognosis or therapy
US20100292299A1 (en) 2006-06-20 2010-11-18 Mendell Joshua T Nucleotide Motifs Providing Localization Elements and Methods of Use
JP2010503382A (ja) * 2006-07-17 2010-02-04 サーナ・セラピューティクス・インコーポレイテッド 低分子干渉核酸（ｓｉＮＡ）を用いたプロタンパク質転換酵素サブチリシンケクシン９（ＰＣＳＫ９）遺伝子発現のＲＮＡ干渉媒介性阻害
WO2008069940A2 (en) 2006-12-06 2008-06-12 Albert Einstein College Of Medicine Of Yeshiva University Multi-microrna methods and compositions
CN101627121A (zh) 2006-12-08 2010-01-13 奥斯瑞根公司 作为治疗干预的靶标的miRNA调控基因和路径
EP2111408A4 (en) 2007-01-17 2010-02-03 Univ Johns Hopkins COMPOSITIONS AND METHODS OF microRNA FOR THE TREATMENT OF NEOPLASIA
AU2008283794B2 (en) 2007-07-31 2014-03-20 Board Of Regents, The University Of Texas System Micro-RNAs that control myosin expression and myofiber identity
US20090148535A1 (en) * 2007-12-06 2009-06-11 Minerva Biotechnologies Corporation Method for treating cancer using interference rna
EP2306978A2 (en) 2008-06-06 2011-04-13 Mirna Therapeutics, Inc. Compositions for the in vivo delivery of rnai agents
JP2010094122A (ja) * 2008-06-12 2010-04-30 Keio Gijuku バイオマーカーとしてのマイクロｒｎａを用いた頭頸部腫瘍の診断・治療選択
WO2010065630A2 (en) * 2008-12-03 2010-06-10 The Johns Hopkins University Compositions and methods for treating hepatic neoplasia
GEP20156329B (en) 2009-06-08 2015-07-27 Miragen Therapeutics CHEMICAL MODIFICATIONS OF miRNA INHIBITORS AND MIMETICS
WO2011034811A1 (en) 2009-09-17 2011-03-24 Sigma-Aldrich Co. Short rna mimetics
US8754059B2 (en) * 2010-02-16 2014-06-17 University Of Miami Use of miR-30e to treat vascular lesions
WO2011143660A2 (en) * 2010-05-14 2011-11-17 Dana-Farber Cancer Institute, Inc. Compositions and methods for treating leukemia
CN103459598B (zh) 2011-02-03 2016-08-10 米尔纳医疗股份有限公司 Mir-124的合成模拟物
SG10201600836PA (en) 2011-02-03 2016-03-30 Mirna Therapeutics Inc Synthetic mimics of mir-34
GB201102283D0 (en) * 2011-02-09 2011-03-23 Ucl Business Plc Treatment
AU2013201303C1 (en) 2011-10-06 2016-06-23 MiRagen Therapeutics, Inc. Control of whole body energy homeostasis by microRNA regulation
US8846633B2 (en) * 2011-11-07 2014-09-30 Taipei Veterans General Hospital Method for inhibiting cancer stem cell like properties and chemoradioresistant properties of cancer or tumor cells with microRNA145
WO2014117050A2 (en) * 2013-01-26 2014-07-31 Mirimus, Inc. Modified mirna as a scaffold for shrna
DK2963125T3 (da) * 2013-02-15 2020-10-12 Univ Nat Corp Tokyo Medical & Dental Terapeutisk middel til behandling af en cancer, hvor NRF2 er stabiliseret
US9518300B2 (en) * 2014-04-14 2016-12-13 Dana-Farber Cancer Institute, Inc. Composition and method for treating a hematological malignancy
DK3134130T3 (da) * 2014-04-25 2019-08-26 Childrens Medical Center Sammensætninger og fremgangsmåder til behandling af hæmoglobinopatier

Similar Documents

Publication Publication Date Title
JP2019512489A5 (enExample)
Nahand et al. Exosomal microRNAs: novel players in cervical cancer
Sun et al. Effect of exosomal miRNA on cancer biology and clinical applications
Liu et al. An aptamer-based probe for molecular subtyping of breast cancer
Shi et al. Potential involvement of miR-375 in the premalignant progression of oral squamous cell carcinoma mediated via transcription factor KLF5
Xue et al. Downregulation of LINC00460 decreases STC2 and promotes autophagy of head and neck squamous cell carcinoma by up-regulating microRNA-206
Zhu et al. Let-7c microRNA expression and clinical significance in hepatocellular carcinoma
Yanaihara et al. MicroRNA involvement in human cancers
CN111733237A (zh) 长链非编码rna lamp5-as1在mll-r白血病中的应用
Almasi et al. Development of a single stranded DNA aptamer as a molecular probe for lncap cells using cell-selex
Li et al. MicroRNA-133b inhibits proliferation, cellular migration, and invasion via targeting LASP1 in hepatocarcinoma cells
da Silva et al. High OCT4A levels drive tumorigenicity and metastatic potential of medulloblastoma cells
CN107828888B (zh) 环状RNA circ-PTPRA的用途
CN108342482A (zh) 一种胶质母细胞瘤标记物及其应用、试剂盒
CN110117657B (zh) 环状RNA hsa_circ_0004872在胃癌诊断中的应用
Yu et al. A polymorphism within ErbB4 is associated with risk for hepatocellular carcinoma in Chinese population
CN105462975B (zh) 一种特异性抑制ctgf基因表达的小干扰rna及其应用
CN106244592B (zh) 一种长非编码rna及其在诊断/治疗非小细胞肺癌中的应用
Gong et al. miR-9875 functions in antiviral immunity by targeting PDCD6 in mud crab (Scylla paramamosain)
Russo et al. Circulating noncoding RNAs as clinical biomarkers
CN105457041A (zh) miR-26a在非小细胞肺癌中的应用
JP2014523736A5 (enExample)
CN110117658B (zh) 环状RNA hsa_circ_0004872用于胃癌治疗的新用途
CN109453385B (zh) 一种用于治疗癌症的组合物及其应用
CN105462976A (zh) 一种特异性抑制twist1基因表达的小干扰rna及其应用